Jazz Pharmaceuticals

This Week: Big week for banks as SME lending stays weak amid Brexit caution

The last 12 months proved to be another year of mixed fortunes in corporate Ireland

National Analytics Conference takes place in Dublin, results due from Liberty Media

US opioid crisis helped growth of overdose rescue drug marketed by Adapt Pharma

Dublin-headquartered pharma company bringing new drugs to market this year

Figures for car sales in July to give pointer to performance for remainder of year

FDA move means Irish company could receive voucher ultimately worth up to €300m

Employment law conference to address ‘increasingly restrictive’ legislation

Your upcoming week in business: retail sales and AIB results plus UK housing prices

There’s the Web Summit in Lisbon, Portugal, plus results from Avis Budget and Trip Advisor

Bill Maris, founder of GV – formerly Google Ventures – among those to invest in Teckro

Jazz Pharmaceuticals affirms full year guidance despite challenges with two drugs

Company’s Xyrem sales were up 16% last year and accounted for more than $1bn of revenue

Company says increases attributed to higher sales of Xyrem and Defitelio in 2016

Proposal to move 30 sq km of the south county into Co Westmeath rejected by review

‘We will not be proceeding with this land grab,’ says Minister of plan for Athlone area

Institute of Directors wants Irish NEDs to have same tax break as non-execs travelling from abroad

Jazz Pharmaceuticals takes 4,088sq m in former St Martin’s House on Waterloo Road

Speciality drug business blames recent acquisition and guidance from SEC

Nasdaq-listed specialty drug group expects to create 50 new jobs over three years

Company accounts show Waterford Distillers recorded €564,214 loss last year

Government’s plan to revise border sparks opposition across the county and abroad